Views & Analysis
Category :
Views & Analysis
/
Digital and Social Media
Newsletters and Deep Dive digital magazine
Bristol-Myers Squibb’s hopes of adding a new indication to the label for S1P modulator Zeposia have been dented after the drug failed a phase 3 trial in Crohn’s disease.
The UK government plans to link the NHS App to data generated by smart devices, including step counts and heart rate, for example, according to Health Secretary Victoria A
Explore “Innovation as Strategy” framework, providing a guide for employing innovative strategies in life sciences.
Over the last five years, a confluence of trends have combined to reshape the reality of clinical research. COVID-19 pushed decentralised trials into the mainstream.
It will come as no surprise to anyone in the healthcare space that doctors today are under an inordinate amount of pressure.
We are living in an era of unprecedented advances in cancer treatments with transformative therapies being regularly approved.
The PM Society Digital Awards 2024 have opened for entries!
Exciting developments in the world of peptides!
Get in-depth news, opinions and features on pharma and healthcare sent straight to your inbox